KalVista meets main goals in late-stage trial for skin condition treatment
By Thomson ReutersFeb 13, 2024 | 5:43 AM
(Reuters) – KalVista Pharmaceuticals said on Tuesday its therapy for a type of skin condition met the main goals in a late-stage trial.
(Reporting by Christy Santhosh; Editing by Shilpi Majumdar)
For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at 715-842-1672.
